India Plasma Fractionation Market (2026-2032) | Competitive Landscape, Forecast, Trends, Analysis, Segmentation, Size & Revenue, Industry, Companies, Growth, Value, Share, Outlook

Market Forecast By Product Type (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes) And Competitive Landscape

Product Code: ETC7551136 Publication Date: Sep 2024 Updated Date: Jan 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

India Plasma Fractionation Market Growth Rate

According to 6Wresearch internal database and industry insights, the India Plasma Fractionation Market is projected to grow at a compound annual growth rate (CAGR) of 8.4% during the forecast period (2026-2032).

Five-Year Growth Trajectory of the India Plasma Fractionation Market with Core Drivers

Below mentioned is the evaluation of year-wise growth rate along with key growth drivers:

Year Est. Annual Growth (%) Growth Drivers
2021 610.00% Increase in healthcare investments and plasma collection centres
2022 680.00% Rising demand for immunoglobulin and coagulation factor concentrates
2023 720.00% Expansion of healthcare infrastructure and better diagnostics
2024 760.00% Growing prevalence of chronic diseases and genetic disorders
2025 800.00% Increase in public-private partnerships supporting plasma-based therapies

Topics Covered in the India Plasma Fractionation Market Report

The India Plasma Fractionation Market report thoroughly covers the market by Product Type, Application and End-User. The market report provides an unbiased and detailed analysis of ongoing market trends, opportunities/high growth areas, and market drivers, which help stakeholders devise and align their market strategies according to the current and future market dynamics.

India Plasma Fractionation Market Highlights

Report Name India Plasma Fractionation Market
Forecast Period 2026–2032
CAGR 8.40%
Growing Sector Hospitals and Clinics

India Plasma Fractionation Market Synopsis

India Plasma Fractionation Market is anticipated to witness significant growth due to increasing demand for plasma-derived products, such as immunoglobulin, albumin, and coagulation factors. Factors such as the expansion of plasma collection infrastructure, government healthcare initiatives, and greater awareness of plasma-based treatments are fueling market growth. Rising cases of chronic conditions, coupled with a growing number of hospitals and healthcare centers, will continue to drive India Plasma Fractionation Market Growth in the coming years.

Evaluation of Growth Drivers in the India Plasma Fractionation Market

Below mentioned are some prominent drivers and their influence on the market dynamics:

Drivers Primary Segments Affected Why it Matters (Evidence)
Increased Demand for Immunoglobulin Immunoglobulin, Hospitals Growing need for immunotherapy treatments for autoimmune diseases.
Growth in Healthcare Infrastructure Coagulation Factor Concentrates, Clinics More specialized facilities are improving access to plasma therapies.
Expanding Plasma Collection Programs All Plasma Products, Hospitals Government and NGO-backed programs have improved plasma collection and distribution.
Rising Prevalence of Chronic Diseases Albumin, Clinical Research Laboratories Chronic conditions are increasing the demand for plasma-derived therapies.
Regulatory Support for Plasma Products All Plasma Products, Clinics Relaxed regulations on plasma-derived product approvals support market growth.

India Plasma Fractionation Market is expected to grow at the CAGR of 8.4% during the forecast period of 2026-2032. The drivers for growth are the rise in chronic diseases, investment in the healthcare sector by governments as well as private companies, and the development of plasma collection networks. The encouragement of plasma programs by the government as well as raising awareness about plasma therapies has helped increase the use of plasma fractionation products.

Evaluation of Restraints in the India Plasma Fractionation Market

Below mentioned are some major restraints and their influence on the market dynamics:

Restraints Primary Segments Affected What This Means (Evidence)
High Cost of Plasma-Derived Products All Plasma Products, Clinics High cost of production leads to affordability issues in low-income regions.
Limited Plasma Donation Awareness All Plasma Products, Hospitals Lack of awareness on plasma donation limits the growth of collection programs.
Complex Regulatory Approvals All Plasma Products, Hospitals Complex approval processes from regulatory authorities cause a delay in the entry of new products.
Insufficient Trained Medical Personnel Immunoglobulin, Hospitals Lack of enough professionals will have a direct impact on health care in plasma therapy.
Infrastructure Gaps in Rural Areas All Plasma Products, Clinics The lack of easy access to plasma-based therapeutic options in remote areas is a hindrance for growth.

India Plasma Fractionation Market Challenges

Irrespective of massive growth and development, the India Plasma Fractionation Market faces several challenges, including high production costs, limited plasma collection infrastructure in rural areas, and a shortage of trained medical professionals. In addition to this, regulatory hurdles and awareness gaps in plasma donation are factors that continue to impede the market's growth, making it difficult to meet the increasing demand for plasma therapies.

India Plasma Fractionation Market Trends

Key trends evaluating the landscape of the India Plasma Fractionation Market are:

  • Increased Focus on Immunoglobulin: Rising demand for immunoglobulin treatments for various autoimmune disorders is driving market growth.
  • Expanding Plasma Donation Programs: Through government-private sector collaboration, the volume of donations is increasing along with the availability for therapies.
  • Use of Advanced Plasma Fractionation Technologies: Adoption of state-of-the-art fractionation methods for producing high-quality plasma products is growing.

Investment Opportunities in the India Plasma Fractionation Market

Major investment opportunities that are part of the India Plasma Fractionation market are:

  • Plasma Collection Centres - Development of plasma collection centres in areas of need.
  • Affordable Plasma Products Distribution - Developing a network for distributing affordable plasma-based products.
  • Plasma Products R&D - Focus to be given to developing new and low-cost methods for plasma fractionation.

Top 5 Leading Players in the India Plasma Fractionation Market

Prominent players making an impact in the India Plasma Fractionation Industry include:

1. Grifols

Company Name Grifols
Established Year 1940
Headquarters Barcelona, Spain
Official Website Click Here

Grifols manufactures plasma-derived medicines and is one of the global leaders in plasma fractionation, helping meet India's growing demand for plasma-based treatments.

2. CSL Behring

Company Name CSL Behring
Established Year 1904
Headquarters King of Prussia, USA
Official Website Click Here

CSL Behring provides a wide range of plasma-based therapies, including immunoglobulin and coagulation factor concentrates, used in the treatment of various diseases in India.

3. Octapharma

Company Name Octapharma
Established Year 1983
Headquarters Lachen, Switzerland
Official Website Click Here

Octapharma supplies high-quality human plasma products, including albumin, immunoglobulin, and coagulation factors, to India’s healthcare sector.

4. Biotest AG

Company Name Biotest AG
Established Year 1946
Headquarters Dreieich, Germany
Official Website Click Here

Biotest focuses on immunoglobulin and albumin products, enhancing the availability of vital plasma therapies across India.

5. Human BioSciences

Company Name Human BioSciences
Established Year 1999
Headquarters New Delhi, India
Official Website Click Here

Human BioSciences is a leading Indian company offering a wide array of plasma-based therapies, contributing significantly to India’s plasma fractionation market.

Government Regulations Introduced in the India Plasma Fractionation Market

According to Indian Government Data, multiple initiatives have been undertaken for the development of the plasma fractionation market. For example, the Indian Ministry of Health and Family Welfare introduced the NBTC guidelines to ensure the safe collection and processing of plasma. The policies further facilitate the importation of the starting materials for plasma therapies with minimum regulatory barriers, making plasma-derived medicines more accessible to the population in India.

Future Insights of the India Plasma Fractionation Market

The outlook for the India Plasma Fractionation Industry promises significant investments in plasma collection infrastructure, rising awareness related to healthcare, and increasing demand for plasma-based therapies. Going forward, an expanded plasma collection program, government initiatives aimed at improving access to healthcare, and increased collaboration between international and local players will make this market ever so beneficial. Such developments are likely to drive market growth, increase access to plasma-derived therapies, and further strengthen the market landscape.

Market Segmentation Analysis

The report offers a comprehensive study of the subsequent market segments and their leading categories:

Neurology to dominate the market - By Application

According to Akshay, Senior Research Analyst, 6Wresearch, neurology is expected to dominate the India Plasma Fractionation Market due to the increasing prevalence of neurological disorders such as multiple sclerosis, autoimmune encephalitis, and Guillain-Barré syndrome, which require plasma-derived therapies like immunoglobulin. 

Hospitals and Clinics to dominate the market - By End-User

Hospitals and Clinics are anticipated to dominate the India Plasma Fractionation Market Share due to their role in providing primary access to plasma-derived therapies for patients. With the growing healthcare infrastructure and an increasing number of patients seeking plasma treatments for conditions like immune deficiencies and bleeding disorders, hospitals and clinics are expected to capture the largest share. 

Key Attractiveness of the Report

  • 10 Years of Market Numbers.
  • Historical Data Starting from 2022 to 2025.
  • Base Year: 2025.
  • Forecast Data until 2032.
  • Key Performance Indicators Impacting the Market.
  • Major Upcoming Developments and Projects.

Key Highlights of the Report:

  • India Plasma Fractionation Market Outlook
  • Market Size of India Plasma Fractionation Market, 2025
  • Forecast of India Plasma Fractionation Market, 2032
  • Historical Data and Forecast of India Plasma Fractionation Revenues & Volume for the Period 2022- 2032F
  • India Plasma Fractionation Market Trend Evolution
  • India Plasma Fractionation Market Drivers and Challenges
  • India Plasma Fractionation Price Trends
  • India Plasma Fractionation Porter's Five Forces
  • India Plasma Fractionation Industry Life Cycle
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Product Type for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Immunoglobulin for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Coagulation Factor Concentrates for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Albumin for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Protease Inhibitors for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Other Plasma Products for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Application for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Neurology for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Immunology for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Hematology for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Critical Care for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Pulmonology for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Others for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By End-User for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Hospitals and Clinics for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Clinical Research Laboratories for the Period 2022- 2032F
  • Historical Data and Forecast of India Plasma Fractionation Market Revenues & Volume By Academic Institutes for the Period 2022- 2032F
  • India Plasma Fractionation Import Export Trade Statistics
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End-User
  • India Plasma Fractionation Top Companies Market Share
  • India Plasma Fractionation Competitive Benchmarking By Technical and Operational Parameters
  • India Plasma Fractionation Company Profiles
  • India Plasma Fractionation Key Strategic Recommendations

Market Covered

The report offers a comprehensive study of the subsequent market segments:

By Product Type

  • Immunoglobulin
  • Coagulation Factor Concentrates
  • Albumin
  • Protease Inhibitors
  • Other Plasma Products

By Application

  • Neurology
  • Immunology
  • Hematology
  • Critical Care
  • Pulmonology
  • Others

By End-User

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

India Plasma Fractionation Market (2026-2032): FAQs

India Plasma Fractionation Market is projected to grow at a CAGR of 8.4% between 2026-2032.
Growth is driven by increased demand for plasma-derived products, expanding healthcare infrastructure, and government support for plasma programs.
The threats lies in the fact that production entails high costs, and there is less awareness concerning the process of donating plasma.
Trends include an increased focus on immunoglobulin, rising plasma collection programs, and the adoption of advanced plasma fractionation technologies.
6Wresearch actively monitors the India Plasma Fractionation Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the India Plasma Fractionation Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary
2 Introduction
2.1 Key Highlights of the Report
2.2 Report Description
2.3 Market Scope & Segmentation
2.4 Research Methodology
2.5 Assumptions
3 India Plasma Fractionation Market Overview
3.1 India Country Macro Economic Indicators
3.2 India Plasma Fractionation Market Revenues & Volume, 2022 & 2032F
3.3 India Plasma Fractionation Market - Industry Life Cycle
3.4 India Plasma Fractionation Market - Porter's Five Forces
3.5 India Plasma Fractionation Market Revenues & Volume Share, By Product Type, 2022 & 2032F
3.6 India Plasma Fractionation Market Revenues & Volume Share, By Application, 2022 & 2032F
3.7 India Plasma Fractionation Market Revenues & Volume Share, By End-User, 2022 & 2032F
4 India Plasma Fractionation Market Dynamics
4.1 Impact Analysis
4.2 Market Drivers
4.2.1 Increasing prevalence of chronic diseases in India, driving the demand for plasma-derived therapies.
4.2.2 Rising healthcare expenditure and investments in healthcare infrastructure in India.
4.2.3 Growing awareness about plasma fractionation therapies among healthcare professionals and patients.
4.3 Market Restraints
4.3.1 High cost associated with plasma fractionation process and therapies, limiting affordability for some patients.
4.3.2 Stringent regulatory requirements for plasma fractionation in India, leading to higher barriers to entry for new market players.
4.3.3 Limited availability of plasma donors in India, impacting the supply of plasma for fractionation.
5 India Plasma Fractionation Market Trends
6 India Plasma Fractionation Market, By Types
6.1 India Plasma Fractionation Market, By Product Type
6.1.1 Overview and Analysis
6.1.2 India Plasma Fractionation Market Revenues & Volume, By Product Type, 2022 & 2032F
6.1.3 India Plasma Fractionation Market Revenues & Volume, By Immunoglobulin, 2022 & 2032F
6.1.4 India Plasma Fractionation Market Revenues & Volume, By Coagulation Factor Concentrates, 2022 & 2032F
6.1.5 India Plasma Fractionation Market Revenues & Volume, By Albumin, 2022 & 2032F
6.1.6 India Plasma Fractionation Market Revenues & Volume, By Protease Inhibitors, 2022 & 2032F
6.1.7 India Plasma Fractionation Market Revenues & Volume, By Other Plasma Products, 2022 & 2032F
6.2 India Plasma Fractionation Market, By Application
6.2.1 Overview and Analysis
6.2.2 India Plasma Fractionation Market Revenues & Volume, By Neurology, 2022 & 2032F
6.2.3 India Plasma Fractionation Market Revenues & Volume, By Immunology, 2022 & 2032F
6.2.4 India Plasma Fractionation Market Revenues & Volume, By Hematology, 2022 & 2032F
6.2.5 India Plasma Fractionation Market Revenues & Volume, By Critical Care, 2022 & 2032F
6.2.6 India Plasma Fractionation Market Revenues & Volume, By Pulmonology, 2022 & 2032F
6.2.7 India Plasma Fractionation Market Revenues & Volume, By Others, 2022 & 2032F
6.3 India Plasma Fractionation Market, By End-User
6.3.1 Overview and Analysis
6.3.2 India Plasma Fractionation Market Revenues & Volume, By Hospitals and Clinics, 2022 & 2032F
6.3.3 India Plasma Fractionation Market Revenues & Volume, By Clinical Research Laboratories, 2022 & 2032F
6.3.4 India Plasma Fractionation Market Revenues & Volume, By Academic Institutes, 2022 & 2032F
7 India Plasma Fractionation Market Import-Export Trade Statistics
7.1 India Plasma Fractionation Market Export to Major Countries
7.2 India Plasma Fractionation Market Imports from Major Countries
8 India Plasma Fractionation Market Key Performance Indicators
8.1 Average waiting time for plasma fractionation services in India.
8.2 Number of plasma fractionation centers opening in key regions of India.
8.3 Percentage of healthcare professionals trained in plasma fractionation therapies in India.
9 India Plasma Fractionation Market - Opportunity Assessment
9.1 India Plasma Fractionation Market Opportunity Assessment, By Product Type, 2022 & 2032F
9.2 India Plasma Fractionation Market Opportunity Assessment, By Application, 2022 & 2032F
9.3 India Plasma Fractionation Market Opportunity Assessment, By End-User, 2022 & 2032F
10 India Plasma Fractionation Market - Competitive Landscape
10.1 India Plasma Fractionation Market Revenue Share, By Companies, 2025
10.2 India Plasma Fractionation Market Competitive Benchmarking, By Operating and Technical Parameters
11 Company Profiles
12 Recommendations
13 Disclaimer

 

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence